Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical bupivacaine-based analgesia after lumbar disc surgery
IRCT20200214046488N1Phase 3Completed
- Sponsor
- Zanjan University of Medical Sciences
- Start
- Sep 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, double-blind trial of bupivacaine, epinephrine and dexamethasone in Lumbar disc disorder (LDD) (4 arms), sponsored by Zanjan University of Medical Sciences. Primary endpoints: Postoperative pain at 3 hours, Postoperative pain at 6 hours and 2 more. Started Sep 2019; status: completed.
02
Drugs
bupivacaineepinephrinedexamethasone
03
Conditions
Lumbar disc disorder (LDD)
Beyond the preview
Go deeper on IRCT20200214046488N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200214046488N1.